Hyperosmolar hyperglycemic state
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
Look out for this icon: for treatment options that are affected, or added, as a result of your patient's comorbidities.
all patients
intravenous fluid therapy
In the setting of severe volume deficit and shock, and in the absence of cardiac compromise, patients should receive 0.9% sodium chloride or balanced crystalloid at a rate of 500-1000 mL/hour over the first 2-4 hours, aiming to replace 50% of estimated fluid deficit in first 8-12 hours.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com [47]Diabetes Canada Clinical Practice Guidelines Expert Committee, Goguen J, Gilbert J. Hyperglycemic emergencies in adults. Can J Diabetes. 2018 Apr;42(suppl 1):S109-14. https://www.canadianjournalofdiabetes.com/article/S1499-2671(17)30823-7/fulltext http://www.ncbi.nlm.nih.gov/pubmed/29650082?tool=bestpractice.com Choice and rate of fluid replacement after restoration of intravascular volume depends on hydration status assessment (blood pressure, heart rate, fluid input and output, and sodium levels), and estimated deficits should be replaced within 24-48 hours.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
Older adults, or patients with heart failure or end-stage kidney disease on dialysis, should be treated cautiously, with smaller boluses of isotonic solutions (e.g., 250 mL boluses) and frequent assessment of hemodynamic status.[2]Mustafa OG, Haq M, Dashora U, et al. Management of hyperosmolar hyperglycaemic state (HHS) in adults: an updated guideline from the Joint British Diabetes Societies (JBDS) for inpatient care group. Diabet Med. 2023 Mar;40(3):e15005. https://onlinelibrary.wiley.com/doi/10.1111/dme.15005 http://www.ncbi.nlm.nih.gov/pubmed/36370077?tool=bestpractice.com [55]Galindo RJ, Pasquel FJ, Fayfman M, et al. Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis. BMJ Open Diabetes Res Care. 2020 Feb;8(1):e000763. https://drc.bmj.com/content/8/1/e000763.long http://www.ncbi.nlm.nih.gov/pubmed/32111715?tool=bestpractice.com In such patients, the use of a standard fluid replacement protocol may be associated with treatment-related complications including volume overload, mechanical ventilation, and longer length of stay.[55]Galindo RJ, Pasquel FJ, Fayfman M, et al. Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis. BMJ Open Diabetes Res Care. 2020 Feb;8(1):e000763. https://drc.bmj.com/content/8/1/e000763.long http://www.ncbi.nlm.nih.gov/pubmed/32111715?tool=bestpractice.com
Plus – supportive care ± intensive care unit (ICU) admission
supportive care ± intensive care unit (ICU) admission
Treatment recommended for ALL patients in selected patient group
Glucose should be checked every 1-2 hours until hyperglycemia is corrected.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com Electrolytes, blood urea nitrogen (BUN), venous pH, osmolality, and creatinine should be checked every 2-4 hours, depending on the patient's clinical condition and response to therapy. Urinary output should be monitored.
Patients with hemodynamic, cardiovascular, or respiratory instability or altered mental status may require ICU admission with frequent blood pressure and hemodynamic monitoring, a central venous catheter and/or Swan-Ganz catheterization, and continuous percutaneous oximetry.
Oxygenation and airway protection are crucial. Intubation and mechanical ventilation may be indicated, with constant monitoring of respiratory parameters.
How to insert a tracheal tube in an adult using a laryngoscope.
How to use bag-valve-mask apparatus to deliver ventilatory support to adults. Video demonstrates the two-person technique.
identify and treat any precipitating factors
Treatment recommended for ALL patients in selected patient group
Diagnosis of precipitating factors (e.g., infection, causative drugs) and appropriate treatment with antibiotics and removal of the offending drug should be initiated.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
Examples of causative drugs include: corticosteroids; thiazide diuretics; beta-blockers; pentamidine; phenytoin and atypical antipsychotics (in particular, clozapine and olanzapine).[26]Alavi IA, Sharma BK, Pillay VK. Steroid-induced diabetic ketoacidosis. Am J Med Sci. 1971 Jul;262(1):15-23. http://www.ncbi.nlm.nih.gov/pubmed/4327634?tool=bestpractice.com [27]Nardone DA, Bouma DJ. Hyperglycemia and diabetic coma: possible relationship to diuretic-propranolol therapy. South Med J. 1979 Dec;72(12):1607-8. http://www.ncbi.nlm.nih.gov/pubmed/515777?tool=bestpractice.com [28]Diamond MT. Hyperglycemic hyperosmolar coma associated with hydrochlorothiazide and pancreatitis. N Y State J Med. 1972 Jul 1;72(13):1741-2. http://www.ncbi.nlm.nih.gov/pubmed/4504065?tool=bestpractice.com [29]Podolsky S, Pattavina CG. Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy. Metabolism. 1973 May;22(5):685-93. http://www.ncbi.nlm.nih.gov/pubmed/4145086?tool=bestpractice.com [30]Carter BL, Small RE, Mandel MD, et al. Phenytoin-induced hyperglycemia. Am J Hosp Pharm. 1981 Oct;38(10):1508-12. http://www.ncbi.nlm.nih.gov/pubmed/7294047?tool=bestpractice.com [32]Newcomer JW. Second generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(suppl 1):1-93. http://www.ncbi.nlm.nih.gov/pubmed/15998156?tool=bestpractice.com [33]Wilson DR, D'Souza L, Sarkar N, et al. New-onset diabetes and ketoacidosis with atypical antipsychotics. Schizophr Res. 2003 Jan 1;59(1):1-6. http://www.ncbi.nlm.nih.gov/pubmed/12413635?tool=bestpractice.com
vasopressor
Treatment recommended for SOME patients in selected patient group
If hypotension persists after fluid resuscitation, a vasopressor agent should be started.[56]Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143. https://www.doi.org/10.1097/CCM.0000000000005337 http://www.ncbi.nlm.nih.gov/pubmed/34605781?tool=bestpractice.com
Patients requiring vasoactive drugs (vasopressor and/or inotrope) need continuous monitoring in a critical care setting.
Consult a specialist for guidance on suitable vasopressor regimens.
potassium therapy with frequent serum measurements
Treatment recommended for ALL patients in selected patient group
Insulin therapy, correction of acidosis, volume expansion, and increased urinary loss of potassium decrease serum potassium. Within 48 hours of admission, potassium levels typically decline by 1-2 mEq/L in patients with diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS), and mixed DKA/HHS. To prevent hypokalemia, potassium replacement should be started after serum levels fall below 5 mEq/L with the aim of maintaining a potassium level of 4-5 mEq/L.
Potassium should be added to maintenance fluid therapy for patients who are normokalemic or hypokalemic.[47]Diabetes Canada Clinical Practice Guidelines Expert Committee, Goguen J, Gilbert J. Hyperglycemic emergencies in adults. Can J Diabetes. 2018 Apr;42(suppl 1):S109-14. https://www.canadianjournalofdiabetes.com/article/S1499-2671(17)30823-7/fulltext http://www.ncbi.nlm.nih.gov/pubmed/29650082?tool=bestpractice.com If baseline serum potassium is <3.5 mEq/L insulin therapy should be delayed and potassium should be replaced until >3.5 mEq/L (guidelines suggest replacement with 10-20 mEq potassium per liter of infusion fluid).[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
Serial potassium measurements should be monitored every 2-4 hours, and potassium replacement should then be given as needed to maintain a potassium level of 4-5 mEq/L.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
Plus – insulin therapy once serum potassium measurement >3.5 mEq/L
insulin therapy once serum potassium measurement >3.5 mEq/L
Treatment recommended for ALL patients in selected patient group
A continuous intravenous infusion of regular insulin is usually recommended if the serum potassium is >3.5 mEq/L.
Insulin can be started with a bolus followed by continuous infusion. Local protocols should be followed. If the serum glucose does not fall by at least 10% in the first hour, then a further bolus of intravenous insulin should be administered, while continuing the previous insulin infusion rate. Once the blood glucose reaches 250 mg/dL or less, the insulin infusion should be reduced, while maintaining the blood glucose between 200 and 250 mg/dL, until resolution.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
Primary options
insulin regular: consult local protocol for dose guidelines
These drug options and doses relate to a patient with no comorbidities.
Primary options
insulin regular: consult local protocol for dose guidelines
Drug choice, dose and interactions may be affected by the patient's comorbidities. Check your local drug formulary.
Show drug information for a patient with no comorbidities
Primary options
insulin regular
phosphate therapy
Treatment recommended for SOME patients in selected patient group
There are limited data on phosphate deficiency or the effects of phosphate replacement in hyperosmolar hyperglycemic state, and routine phosphate replacement is not recommended.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com [3]Stoner GD. Hyperosmolar hyperglycemic state. Am Fam Physician. 2017 Dec 1;96(11):729-36. https://www.aafp.org/afp/2017/1201/p729.html http://www.ncbi.nlm.nih.gov/pubmed/29431405?tool=bestpractice.com In the presence of severe hypophosphatemia (<1 mg/dL) in patients with cardiac dysfunction (e.g., with signs of left ventricular dysfunction), symptomatic anemia, or respiratory depression (e.g., decreased oxygen saturation), careful phosphate therapy may be indicated to avoid cardiac, respiratory, and skeletal muscle dysfunction.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
insulin therapy
Treatment recommended for ALL patients in selected patient group
A continuous intravenous infusion of regular insulin is usually recommended if the serum potassium is >3.5 mEq/L.
The insulin can be started with a bolus followed by a continuous infusion. Local protocols should be followed. If the serum glucose does not fall by at least 10% in the first hour, then a further bolus of intravenous insulin should be administered, while continuing the previous insulin infusion rate. Once the blood glucose reaches 250 mg/dL or less, the insulin infusion should be reduced, while maintaining the blood glucose between 200 and 250 mg/dL, until resolution.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
Primary options
insulin regular: consult local protocol for dose guidelines
These drug options and doses relate to a patient with no comorbidities.
Primary options
insulin regular: consult local protocol for dose guidelines
Drug choice, dose and interactions may be affected by the patient's comorbidities. Check your local drug formulary.
Show drug information for a patient with no comorbidities
Primary options
insulin regular
potassium therapy with frequent serum measurements
Treatment recommended for ALL patients in selected patient group
Insulin therapy, correction of acidosis, volume expansion, and increased urinary loss of potassium decrease serum potassium. Within 48 hours of admission, potassium levels typically decline by 1-2 mEq/L in patients with diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS), and mixed DKA/HHS.
Potassium should be added to maintenance fluid therapy for patients who are normokalemic or hypokalemic.[47]Diabetes Canada Clinical Practice Guidelines Expert Committee, Goguen J, Gilbert J. Hyperglycemic emergencies in adults. Can J Diabetes. 2018 Apr;42(suppl 1):S109-14. https://www.canadianjournalofdiabetes.com/article/S1499-2671(17)30823-7/fulltext http://www.ncbi.nlm.nih.gov/pubmed/29650082?tool=bestpractice.com
If baseline serum potassium level is between 3.5 and 5.0 mEq/L potassium replacement should be started (guidelines suggest replacement with 10-20 mEq potassium per liter of infusion fluid).[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com Serial potassium measurements should be monitored every 2-4 hours, and potassium replacement should then be given as needed to maintain a potassium level of 4-5 mEq/L.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
Potassium replacement is not needed once the level is >5.0 mEq/L, but potassium levels should be checked every 2 hours in this situation.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com [47]Diabetes Canada Clinical Practice Guidelines Expert Committee, Goguen J, Gilbert J. Hyperglycemic emergencies in adults. Can J Diabetes. 2018 Apr;42(suppl 1):S109-14. https://www.canadianjournalofdiabetes.com/article/S1499-2671(17)30823-7/fulltext http://www.ncbi.nlm.nih.gov/pubmed/29650082?tool=bestpractice.com
phosphate therapy
Treatment recommended for SOME patients in selected patient group
There are limited data on phosphate deficiency or the effects of phosphate replacement in hyperosmolar hyperglycemic state, and routine phosphate replacement is not recommended.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com [3]Stoner GD. Hyperosmolar hyperglycemic state. Am Fam Physician. 2017 Dec 1;96(11):729-36. https://www.aafp.org/afp/2017/1201/p729.html http://www.ncbi.nlm.nih.gov/pubmed/29431405?tool=bestpractice.com
In the presence of severe hypophosphatemia (<1 mg/dL) in patients with cardiac dysfunction (e.g., with signs of left ventricular dysfunction), symptomatic anemia, or respiratory depression (e.g., decreased oxygen saturation), careful phosphate therapy may be indicated to avoid cardiac, respiratory, and skeletal muscle dysfunction.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
insulin therapy
Treatment recommended for ALL patients in selected patient group
A continuous intravenous infusion of regular insulin is usually recommended if the serum potassium is >3.5 mEq/L.
The insulin can be started with a bolus followed by a continuous infusion. Local protocols should be followed. If the serum glucose does not fall by at least 10% in the first hour, then a further bolus of intravenous insulin should be administered, while continuing the previous insulin infusion rate. Once the blood glucose reaches 250 mg/dL or less, the insulin infusion should be reduced, while maintaining the blood glucose between 200 and 250 mg/dL, until resolution.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
Primary options
insulin regular: consult local protocol for dose guidelines
These drug options and doses relate to a patient with no comorbidities.
Primary options
insulin regular: consult local protocol for dose guidelines
Drug choice, dose and interactions may be affected by the patient's comorbidities. Check your local drug formulary.
Show drug information for a patient with no comorbidities
Primary options
insulin regular
monitoring of serum potassium
Treatment recommended for SOME patients in selected patient group
Supplemental potassium is not required if the serum potassium is >5.0 mEq/L, but serum potassium should be checked every 2 hours because insulin therapy and fluid administration reduces potassium levels.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
phosphate therapy
Treatment recommended for SOME patients in selected patient group
There are limited data on phosphate deficiency or the effects of phosphate replacement in hyperosmolar hyperglycemic state, and routine phosphate replacement is not recommended.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com [3]Stoner GD. Hyperosmolar hyperglycemic state. Am Fam Physician. 2017 Dec 1;96(11):729-36. https://www.aafp.org/afp/2017/1201/p729.html http://www.ncbi.nlm.nih.gov/pubmed/29431405?tool=bestpractice.com In the presence of severe hypophosphatemia (<1 mg/dL) in patients with cardiac dysfunction (e.g., with signs of left ventricular dysfunction), symptomatic anemia, or respiratory depression (e.g., decreased oxygen saturation), careful phosphate therapy may be indicated to avoid cardiac, respiratory, and skeletal muscle dysfunction.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
hyperosmolar hyperglycemic state (HHS) resolved and patient able to tolerate oral intake
subcutaneous insulin therapy
Management and monitoring should continue until resolution of HHS. Criteria for resolution of HHS are blood glucose is <250 mg/dL, measured or calculated serum osmolality is <300 mOsm/kg, urine output is >0.5 mL/kg/hour, and cognitive status has improved.[1]Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycaemic crises in adults with diabetes: a consensus report. Diabetologia. 2024 Aug;67(8):1455-79. https://pmc.ncbi.nlm.nih.gov/articles/PMC11343900 http://www.ncbi.nlm.nih.gov/pubmed/38907161?tool=bestpractice.com
Once HHS is resolved transition to subcutaneous insulin is initiated. Subcutaneous insulin should be given 2 hours before the termination of insulin infusion.
Intermediate or long-acting insulin is recommended for basal requirements and short-acting insulin for prandial glycemic control.
Patients already on insulin treatment prior to admission may be continued on the same dose.
Primary options
insulin glargine
or
insulin degludec
or
insulin NPH
-- AND --
insulin lispro
or
insulin aspart
or
insulin glulisine
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer